Skip to content

Juvenile Rheumatoid Arthritis C3714757

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition causing joint inflammation and swelling in children. It most commonly affects those under 16 years old. Treatment aims to reduce pain and inflammation while preserving joint function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
M08.00, M08.011, M08.012
ICD-11
FA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint swelling

(musculoskeletal)

Morning stiffness

(musculoskeletal)

Joint pain

(musculoskeletal)

Limping gait

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

NSAIDs for Inflammation Control

Nonsteroidal anti-inflammatory drugs provide first-line symptomatic relief by reducing joint inflammation and pain. They are typically the initial pharmacologic intervention in JIA management.

medication
3

Disease-Modifying Antirheumatic Drugs

DMARDs slow disease progression and reduce long-term joint damage. Methotrexate is commonly initiated when NSAIDs prove insufficient for disease control.

medication

Additional treatment options

Physical and Occupational Therapy

Targeted exercises maintain joint range of motion, strengthen supporting muscles, and preserve function. Splinting protects joints during inflammation.

physical_therapy

Biologic Response Modifiers

Biologic agents target specific inflammatory pathways when conventional DMARDs are inadequate. Reserved for moderate to severe disease unresponsive to other interventions.

medication

Heat and Cold Therapy

Application of heat relaxes muscles and relieves stiffness while cold reduces acute inflammation and pain. Both modalities complement medical management.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Juvenile Rheumatoid Arthritis C3714757?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(4):465-482.

guideline2011
2

Woo P, Thorne N. Juvenile idiopathic arthritis: current and future therapies. Nat Rev Rheumatol. 2011;7(5):282-290.

review2011
3

Ruperto N, Lovell DJ, Quartier P, et al. Long-term efficacy and safety of tocilizumab for systemic juvenile idiopathic arthritis: a randomized, double-blind, placebo-controlled, crossover trial. Arthritis Rheumatol. 2020;72(4):622-634.

clinical_trial2020
4

Clarke A, Wells G, Dudin A, et al. Biologic therapies for juvenile idiopathic arthritis: a systematic review and meta-analysis. J Rheumatol. 2019;46(8):1043-1056.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Juvenile Rheumatoid Arthritis C3714757. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy